A Phase 2, Randomized, Double-Blind, Active-Controlled Study to Evaluate the Efficacy and Safety of Miconazole Nitrate 2% + Domiphen Bromide Vaginal Cream in the Treatment of Subjects With Acute Vulvovaginal Candidiasis
Latest Information Update: 25 Mar 2024
At a glance
- Drugs Domiphen bromide/miconazole (Primary)
- Indications Vulvovaginal candidiasis; Vulvovaginitis
- Focus Therapeutic Use
- 14 Mar 2024 Status changed from active, no longer recruiting to completed.
- 30 Jan 2024 Top-line Results from this trial presented in a Hyloris Pharmaceuticals media release.
- 06 Sep 2023 According to a Hyloris Pharmaceuticals media release, a full read-out of the study expected shortly.